A detailed history of Tiaa Trust, National Association transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Tiaa Trust, National Association holds 99,517 shares of BMY stock, worth $5.39 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
99,517
Previous 419,445 76.27%
Holding current value
$5.39 Million
Previous $22.7 Million 81.83%
% of portfolio
0.01%
Previous 0.07%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 01, 2024

SELL
$40.25 - $52.99 $12.9 Million - $17 Million
-319,928 Reduced 76.27%
99,517 $4.13 Million
Q1 2024

May 10, 2024

BUY
$47.98 - $54.4 $14.3 Million - $16.2 Million
298,026 Added 245.45%
419,445 $22.7 Million
Q4 2023

Jan 23, 2024

SELL
$48.48 - $57.85 $814,851 - $972,342
-16,808 Reduced 12.16%
121,419 $6.23 Million
Q3 2023

Oct 27, 2023

BUY
$57.89 - $64.73 $8 Million - $8.95 Million
138,227 New
138,227 $8.02 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $115B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Tiaa Trust, National Association Portfolio

Follow Tiaa Trust, National Association and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tiaa Trust, National Association, based on Form 13F filings with the SEC.

News

Stay updated on Tiaa Trust, National Association with notifications on news.